Victoria Ashby
Pharma Regulatory Correspondent|Washington DC, USA
Victoria Ashby covers pharmaceutical regulation and its trade implications for The Trade Signal at Zovora. She tracks FDA approvals, patent lifecycle events, and regulatory data protection periods to analyze how intellectual property regimes affect generic drug market access. Victoria's coverage of patent cliffs, generic entry patterns, and regulatory provisions helps readers understand the commercial implications of regulatory decisions.
Drug approvalspatent lifecycleregulatory frameworks
